Exposure of platelet fibrinogen receptors by ADP and epinephrine.

TLDR

The study measured 125I‑labeled fibrinogen binding to gel‑filtered human platelets before and after stimulation with ADP or epinephrine to assess receptor exposure. Stimulation with ADP or epinephrine rapidly and reversibly exposed ~45,000 fibrinogen receptors per platelet, with binding increasing dose‑dependently, requiring divalent cations, absent in Glanzmann’s thrombasthenia, and indicating that bound fibrinogen directly contributes to platelet aggregation.

Abstract

The role of fibrinogen as a cofactor for platelet aggregation was examined by measuring the binding of 125I-labeled human fibrinogen to gel-filtered human platelets both before and after platelet stimulation by ADP and epinephrine. Platelet stimulation by ADP resulted in the rapid, reversible binding of fibrinogen to receptors on the platelet surface. Fibrinogen binding increased as the concentration of ADP was increased from 0.1 to 2 microM, reaching a plateau at higher ADP concentrations. Binding occurred only after platelet stimulation and in the presence of divalent cations. However, fibrinogen binding did not occur to ADP-stimulated platelets from three patients with Glanzmann's thrombasthenia. Analysis of fibrinogen binding as a function of increasing fibrinogen concentration demonstrated that maximal platelet stimulation exposed approximately or equal to 45,000 binding sites per platelet with a dissociation constant of 80--170 nM. These fibrinogen binding parameters were essentially the same whether ADP or epinephrine was the platelet-stimulating agent. Thus, these studies demonstrate that platelet stimulation by ADP and epinephrine exposes a limited number of fibrinogen receptors on the platelet surface. Furthermore, these data suggest that the fibrinogen molecules bound to the platelet as a consequence of platelet stimulation are directly involved in the platelet aggregation response.